Hanssens 2015.
| Methods | 12‐month longitudinal randomised double‐blind placebo‐controlled trial. |
| Participants | 16 people with CF, homozygous D508, over 5 years of age. |
| Interventions | Randomised to placebo or oral supplement of omega 3, 60 mg/kg. |
| Outcomes | Clinical and nutritional status; lung function; exercise tolerance. |
| Notes | N = 13 completed, 6 intervention, 7 placebo. Supplement well‐tolerated. |